Literature DB >> 16914784

Functional outcome of the hand following flexor tendon repair at the 'no man's land'.

T K Chan1, C O Ho, W K Lee, Y K Fung, Y F Law, C Y Tsang.   

Abstract

PURPOSE: To evaluate the functional outcome of the hand following flexor tendon repair at 'no man's land' using 2 strands of a modified Kessler core suture and combined controlled motion rehabilitation protocol.
METHODS: Records of 31 zone-2 flexor tendon injuries in 21 digits of 16 patients between July 2000 and June 2005 were reviewed retrospectively. The injured tendons were repaired within 24 hours using 2 strands of a modified Kessler core suture, reinforced by a continuous circumferential epitendon suture. All patients completed a rehabilitation protocol that included active extension against a rubber band, passive flexion, and controlled passive extension and passive flexion exercises. Functional outcome of the fingers was assessed using the Buck-Gramcko II score. Hand grip strength, rehabilitation period, and rupture rate were also measured.
RESULTS: 17 (81%) out of 21 digits in 15 out of 16 patients achieved an excellent-to-good functional grade. The remaining patient with concomitant injuries to 4 (19%) digits attained a poor functional grade, attributable to poor compliance with the rehabilitation protocol. The mean rehabilitation period was 130 days and the mean grip strength was 78% that of the uninjured side. Concomitant digital nerve injury did not adversely affect the final outcome. Only one (4.8%) patient experienced a rupture.
CONCLUSION: The surgical method and rehabilitation protocol used for zone-2 flexor tendon injury is safe and results in a reasonably good functional outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16914784     DOI: 10.1177/230949900601400214

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  8 in total

1.  [Early functional passive mobilization of flexor tendon injuries of the hand (zone 2) : Exercise with an exoskeleton compared to physical therapy].

Authors:  Joachim Gülke; Martin Mentzel; Gert Krischak; David Gulkin; Daniel Dornacher; Nikolaus Wachter
Journal:  Unfallchirurg       Date:  2018-07       Impact factor: 1.000

2.  The Effect of the Epitendinous Suture on Gliding in a Cadaveric Model of Zone II Flexor Tendon Repair.

Authors:  Zaneb Yaseen; Christopher English; Spencer J Stanbury; Tony Chen; Susan Messing; Hani Awad; John C Elfar
Journal:  J Hand Surg Am       Date:  2015-04-25       Impact factor: 2.230

3.  Adherence to therapy after flexor tendon surgery at a level 1 trauma center.

Authors:  Serdar Toker; Nikhil Oak; Allison Williams; Kyros Ipaktchi; Kagan Ozer
Journal:  Hand (N Y)       Date:  2014-06

4.  Rehabilitation outcomes in patients with early and two-stage reconstruction of flexor tendon injuries.

Authors:  Ilgin Sade; Murat İnanir; Suzan Şen; Esra Çakmak; Serkan Kablanoğlu; Barin Selçuk; Nigar Dursun
Journal:  J Phys Ther Sci       Date:  2016-08-31

5.  Physical therapy and splinting after flexor tendon repair in zone II.

Authors:  Shkurta Rrecaj; Merita Martinaj; Ardiana Murtezani; Dafina Ibrahimi-Kaçuri; Bekim Haxhiu; Violeta Zatriqi
Journal:  Med Arch       Date:  2014

6.  Flexor Digitorum Superficialis and Flexor Digitorum Profundus with separated sheaths: a new normal variation in human.

Authors:  Seyed Mokhtar Esmaeilnejad-Ganji; Behnam Baghianimoghadam
Journal:  Colomb Med (Cali)       Date:  2015-12-30

7.  Treatment of mild to moderate carpal tunnel syndrome in patients with diabetic neuropathy using low level laser therapy versus ultrasound controlled comparative study.

Authors:  Osama F Ahmed; Ahmed M Elkharbotly; Nahed Taha; Ahmed B Bekheet
Journal:  BBA Clin       Date:  2017-07-20

8.  Prevention of postoperative adhesions after flexor tendon repair with acellular dermal matrix in Zones III, IV, and V of the hand: A randomized controlled (CONSORT-compliant) trial.

Authors:  Yeon Ji Lee; Hyun Jung Ryoo; Hyung-Sup Shim
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.